These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26828696)

  • 21. Circulating tumor cells: clinical validity and utility.
    Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
    Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
    Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
    Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Label-Free Isolation of Circulating Tumor Cells from Patients' Peripheral Blood Using Electrically Charged Fe
    Wu S; Gu L; Qin J; Zhang L; Sun F; Liu Z; Wang Y; Shi D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4193-4203. PubMed ID: 31935069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
    Chen JY; Tsai WS; Shao HJ; Wu JC; Lai JM; Lu SH; Hung TF; Yang CT; Wu LC; Chen JS; Lee WH; Chang YC
    PLoS One; 2016; 11(3):e0149633. PubMed ID: 26938471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of TTF-1 Positive Circulating Tumor Cells for Single-Cell Sequencing by Using an Automatic Platform Based on Microfluidic Devices.
    Jou HJ; Ho HC; Huang KY; Chen CY; Chen SW; Lo PH; Huang PW; Huang CE; Chen M
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.
    Welinder C; Jansson B; Lindell G; Wenner J
    Cancer Lett; 2015 Mar; 358(1):43-6. PubMed ID: 25528628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.
    Bitting RL; Healy P; Halabi S; George DJ; Goodin M; Armstrong AJ
    Urol Oncol; 2015 Mar; 33(3):110.e1-9. PubMed ID: 25595577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bait-trap chip for accurate and ultrasensitive capture of living circulating tumor cells.
    Jiang W; Han L; Li G; Yang Y; Shen Q; Fan B; Wang Y; Yu X; Sun Y; He S; Du H; Miao J; Wang Y; Jia L
    Acta Biomater; 2023 May; 162():226-239. PubMed ID: 36940769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
    Lu Y; Liang H; Yu T; Xie J; Chen S; Dong H; Sinko PJ; Lian S; Xu J; Wang J; Yu S; Shao J; Yuan B; Wang L; Jia L
    Cancer; 2015 Sep; 121(17):3036-45. PubMed ID: 25945459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients.
    Ji JL; Jiang YZ; Tang QQ; He XD; Shen ZJ; Zhang BY
    J Clin Lab Anal; 2016 Sep; 30(5):656-62. PubMed ID: 26987307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
    Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
    PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous PSMA expression on circulating tumor cells: a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer.
    Gorges TM; Riethdorf S; von Ahsen O; Nastał Y P; Röck K; Boede M; Peine S; Kuske A; Schmid E; Kneip C; König F; Rudolph M; Pantel K
    Oncotarget; 2016 Jun; 7(23):34930-41. PubMed ID: 27145459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.